Therapeutic Analysis of Fuzi Lizhong Wan with Trimebutine in the Treatment of Diarrhea Type lrritable Bowel Syndrome  

作　　者：Ying Chang Quanwei Di Gaixian Di 

机构地区：[1]Affiliated Hospital of Hebei University,Baoding 071000,Hebei Province,China [2]Worker's Hospital of China Lucky Group Corporation,Baoding 071000,Hebei Province,China [3]Tangxian Hospital of Traditional Chinese Medicine,Baoding 072350,Hebei Provinc,China

出　　处：《Journal of Clinical and Nursing Research》2020年第4期40-44,共5页临床护理研究（英文）

基　　金：Youth Scientific Research Fund project of Affiliated Hospital of Hebei University(2016Q003)。

摘　　要：Objective:To evaluate the clinical efficacy ofFuzi Lizhong Wan and trimebutine in the treatment of diarrhea irritab1e bowel syndrome.Methods:A tota1 of 90 patients with diarrhea irritable Dow1 syndrome were divided intocontro1 group(n=45)and treatment group(n=45)using the random.number table method.Patients in the control group were po administered withtrimebutine 0.2 g.three time daily for 4 weeks.Patients in the treatment group were po administered with Fuzi Lizhong Wan 9 g,three time daily for 4 weeks on the basis of the control group.The clinical efficacy and the TCM symptom scores were evaluated after treatment.The serological indicators in two groups were compared before and after treatment.Results:After treatment,the clinica1 efficacy and the TCM symptom scores in treatment group were significantly 1ower than that in contro1 group(P<0.05).The 1evels of serological indicators in both groups improved significant1y,and those in the treatment group were better than the control group(P<0.05).Conclusion:Combined therapy of Fuzi Lizhong Wan and trimebutine in the treatment of diarrhea type irritable bowe1 syndrome has a significant effect,which canrelieve clinical symptom;and reduce visceral sensitivity,and improve leve1s of inflammatory and quality of life.So it is suggested to be applied.

关 键 词：Fuzi Lizhong Wan TRIMEBUTINE Diarrhea irritable bowel syndrome 

分 类 号：R57[医药卫生—消化系统]